Oncopeptides AB (ONPPF)
0.265
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
Oncopeptides Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 99.90% |
| March 31, 2023 | 99.02% |
| December 31, 2022 | 98.93% |
| September 30, 2022 | |
| June 30, 2022 |
| Date | Value |
|---|---|
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | 41.79% |
| June 30, 2021 | 95.75% |
| March 31, 2021 | 98.31% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
41.79%
Minimum
Sep 2021
99.90%
Maximum
Jun 2023
88.95%
Average
98.62%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abliva AB | -- |
| BioInvent International AB | -- |
| Hansa Biopharma AB | 76.62% |
| BioArctic AB | 90.35% |
| Camurus AB | 93.01% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -108.3% |
| Return on Assets | -71.90% |
| Return on Invested Capital | -92.02% |
| Profit Margin (Quarterly) | -1.45K% |
| Operating Margin (Quarterly) | -1.33K% |